Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Lyndsay A Richardson, Joseph Tota & Eduardo L Franco. (2011) Optimizing technology for cervical cancer screening in high-resource settings. Expert Review of Obstetrics & Gynecology 6:3, pages 343-353.
Read now
Read now
Mario Poljak & Boštjan J Kocjan. (2010) Commercially available assays for multiplex detection of alpha human papillomaviruses. Expert Review of Anti-infective Therapy 8:10, pages 1139-1162.
Read now
Read now
Magdalena Grce. (2009) Primary and secondary prevention of cervical cancer. Expert Review of Molecular Diagnostics 9:8, pages 851-857.
Read now
Read now
Articles from other publishers (10)
Min Wei, Youguo Chen & Wensheng Du. (2021) LncRNA LINC00858 enhances cervical cancer cell growth through miR-3064-5p/ VMA21 axis. Cancer Biomarkers 32:4, pages 479-489.
Crossref
Crossref
Ena Pešut, Anamaria Đukić, Lucija Lulić, Josipa Skelin, Ivana Šimić, Nina Milutin Gašperov, Vjekoslav Tomaić, Ivan Sabol & Magdalena Grce. (2021) Human Papillomaviruses-Associated Cancers: An Update of Current Knowledge. Viruses 13:11, pages 2234.
Crossref
Crossref
David Guenat, Sophie Launay, Didier Riethmuller, Christiane Mougin & Jean-Luc Pr?tet. (2016) Validation of Novaprep? HQ+ liquid-based cytology medium for high-risk human papillomavirus detection by hc2. Infectious Agents and Cancer 11:1.
Crossref
Crossref
Herve Y. Sroussi, Mahesh Patel, Sara C. Gordon & Robert J. Cabay. 2012. HPV and Cancer. HPV and Cancer
163
181
.
Eduardo Lazcano-Ponce, Attila Tibor Lorincz, Aurelio Cruz-Valdez, Jorge Salmerón, Patricia Uribe, Eduardo Velasco-Mondragón, Pilar Hernandez Nevarez, Rodrigo Diaz Acosta & Mauricio Hernández-Avila. (2011) Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. The Lancet 378:9806, pages 1868-1873.
Crossref
Crossref
Jean-Luc Pr?tet, Chrystelle Vidal, Karine Le Bail Carval, Rajeev Ramanah, Xavier Carcopino, Isabelle Cartier, Eric Labouyrie, Bernadette Kantelip, Sylviane Coumes-Marquet, Didier Riethmuller & Christiane Mougin. (2010) Novaprep? Vial Test is a suitable liquid-based cytology medium for high risk human papillomavirus testing by Hybrid Capture 2. Journal of Clinical Virology 49:4, pages 286-289.
Crossref
Crossref
Victor Lee, Siok-Bian Ng & Manuel Salto-Tellez. 2010. Diagnostic Cytopathology. Diagnostic Cytopathology
891
902
.
Yimin Ge, Debora Smith, Mary R. Schwartz & Dina R. Mody. (2009) Image‐guided ThinPrep Papanicolaou tests and cotesting with high‐risk human papillomavirus in women aged 30 years and older in a low‐risk private practice population. Cancer Cytopathology 117:5, pages 326-332.
Crossref
Crossref
Florian Al. Nicula, Ahti Anttila, Luciana Neamtiu, Maja Primic ?akelj, Ruth Tachezy, Arkadiusz Chil, Magdalena Grce & Vesna Kesi?. (2009) Challenges in starting organised screening programmes for cervical cancer in the new member states of the European Union. European Journal of Cancer 45:15, pages 2679-2684.
Crossref
Crossref
Martina Schmitz, Cornelia Scheungraber, J?rg Herrmann, Karin Teller, Mieczyslaw Gajda, Ingo B. Runnebaum & Matthias D?rst. (2009) Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types. Journal of Clinical Virology 44:4, pages 302-307.
Crossref
Crossref